血清PECAM-1在Ⅳ期胃癌中的表达及意义  被引量:1

Serum PECAM-1 Levels in Stage Ⅳ Gastric Cancer and Its Significance

在线阅读下载全文

作  者:袁梅琴[1] 王增[1] 吕汪霞[1] 史钟[1] 杨云山[1] 赵亚珍[1] 刘碧霞[1] 冯婷婷[1] 钟海均[1] YUAN Mei-qin;WANG Zeng;LV Wang-xia(Zhejiang Cancer Hospital, Hangzhou 310022, China)

机构地区:[1]浙江省肿瘤医院

出  处:《肿瘤学杂志》2018年第5期476-479,共4页Journal of Chinese Oncology

基  金:国家自然科学基金青年项目(81602583);浙江省医药卫生科技项目(2016KYB036);浙江省医药卫生科技项目(2016KYB043)

摘  要:[目的]研究血清PECAM-1表达与胃癌患者预后的相关性,了解其在胃癌发生发展过程中的作用。[方法]入组初诊的Ⅳ期胃癌患者56例,经组织病理确诊、符合本研究入组标准,于入院后未经治疗前采取外周血5ml,运用酶联免疫法(ELISA法)检测外周血中PECAM-1蛋白的表达,分析胃癌患者外周血中PECAM-1蛋白表达水平与预后及临床病理特征的关系。[结果]56例患者的中位总生存时间(m OS)为446d。胃癌患者血清PECAM-1中位值为79.5ng/ml,以该值作为分界值将患者分为高浓度组和低浓度组,PECAM-1高浓度组的m OS低于PECAM-1低浓度组(360d vs 558d,P=0.012)。PECAM-1高浓度组与低浓度组间患者性别、年龄(≥60岁与〈60岁)、一线化疗方案(XELOX与SOX)及周期数(≤4周期与〉4周期)、是否接受二线以上化疗差异均无统计学意义,但PECAM-1低浓度组一线化疗疗效优于高浓度组(P=0.043)。[结论]Ⅳ期胃癌患者血清PECAM-1水平与一线化疗疗效及预后生存可能相关,PECAM-1水平高者预后差,一线化疗疗效差。[Objective] To analyze the relationship between serum PECAM-1 levels and the prognosis in patients with stage Ⅳ gastric cancer. [Methods] Fifty-six patients with stage Ⅳ gastric cancer were enrolled. The serum levels of PECAM-1 was detected by enzyme-linked immunosorbent assay(ELISA). And the relationship of serum PECAM-1 levels with clinical features and survival was analyzed. [Results]The median overall survival time(m OS) of patients was 446 d and the median serum PECAM-1 level was 79.5 ng/ml. The OS in patients with high PECAM-1 level(79.5 ng/ml) was lower than that in those with low PECAM-1(≤79.5 ng/ml)(360 d vs. 558 d,P=0.012). There were no significant differences in gender,age(≥60 years or 60 years),the first-line chemotherapy regimens(XELOX or SOX) and the number of cycles(≤4 cycles or 4 cycles),and receiving further chemotherapy between patients with high and low PECAM-1 levels,but the efficacy of first-line chemotherapy in patients with low PECAM-1 was better than that in patients with high PECAM-1(P=0.043). [Conclusion] The serum PECAM-1 level may be related to the efficacy of first-line chemotherapy and the prognosis in patients with stage Ⅳ gastric cancer.

关 键 词:胃肿瘤 PECAM-1 总生存期 ELISA 

分 类 号:R735.2[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象